About Serenity Pharmaceuticals
Serenity Pharmaceuticals is a company based in York (United States) founded in 2006 was acquired by Acerus Pharma in February 2022.. Serenity Pharmaceuticals has raised $7.89 million across 1 funding round from investors including Acerus Pharma. Serenity Pharmaceuticals operates in a competitive market with competitors including Lipella, TheraVida, Esprit Pharma, Regenfro Co and Kissei Pharmaceutical, among others.
- Headquarter York, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Serenity Pharmaceuticals Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.89 M (USD)
in 1 rounds
-
Latest Funding Round
$7.89 M (USD), Series A
Jul 01, 2016
- Investors
-
Employee Count
Employee Count
-
Acquired by
Acerus Pharma
(Feb 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Serenity Pharmaceuticals
Serenity Pharmaceuticals has successfully raised a total of $7.89M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.89 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $7.9M
-
First Round
First Round
(01 Jul 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Series A - Serenity Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Serenity Pharmaceuticals
Serenity Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Acerus Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Serenity Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Serenity Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Serenity Pharmaceuticals Comparisons
Competitors of Serenity Pharmaceuticals
Serenity Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lipella, TheraVida, Esprit Pharma, Regenfro Co and Kissei Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| domain | founded_year | HQ Location |
Clinical stage biopharma company developing drugs for urology and central nervous system disorders
|
|
| domain | founded_year | HQ Location |
Develop drugs for genitourinary (GU) disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat renal diseases
|
|
| domain | founded_year | HQ Location |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| domain | founded_year | HQ Location |
Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Serenity Pharmaceuticals
Frequently Asked Questions about Serenity Pharmaceuticals
When was Serenity Pharmaceuticals founded?
Serenity Pharmaceuticals was founded in 2006 and raised its 1st funding round 10 years after it was founded.
Where is Serenity Pharmaceuticals located?
Serenity Pharmaceuticals is headquartered in York, United States. It is registered at York, Pennsylvania, United States.
Is Serenity Pharmaceuticals a funded company?
Serenity Pharmaceuticals is a funded company, having raised a total of $7.89M across 1 funding round to date. The company's 1st funding round was a Series A of $7.89M, raised on Jul 01, 2016.
What does Serenity Pharmaceuticals do?
Serenity develops patented pharmaceuticals using unique delivery mechanisms combined with low threshold efficacious formulations. This dual approach allows Serenity to engineer safer drugs with minimal side effects in targeted populations. In Apr 2010, the company out-licensed to Allergan, rights for development and commercialization of Ser-120 (an intranasal formulation of desmopressin), a Phase III investigational drug in clinical development for the treatment of nocturia, a common yet often under-diagnosed urological disorder in adults characterized by frequent urination at night time.
Who are the top competitors of Serenity Pharmaceuticals?
Serenity Pharmaceuticals's top competitors include Lipella, Kissei Pharmaceutical and Regenfro Co.
Who are Serenity Pharmaceuticals's investors?
Serenity Pharmaceuticals has 1 investor. Key investors include Acerus Pharma.